Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
09/1995
09/08/1995WO1995023608A1 Antithrombotic agents
09/08/1995CA2184188A1 Antithrombotic agents
09/08/1995CA2184058A1 Kunitz domain inhibitor proteins derived from alzheimer's amyloid .beta.-protein precursor inhibitor
09/08/1995CA2183643A1 Products comprising substrates capable of enzymatic cross-linking
09/08/1995CA2183464A1 Antithrombotic agents
09/08/1995CA2180141A1 Antithrombotic agents
09/06/1995EP0670332A2 Protein complexes having factor VIII:C activity and production thereof
09/06/1995EP0670331A1 Process to reactivate purified membrane proteins by freezing
09/06/1995EP0670310A1 Bisulfite adducts of arginine aldehydes useful as thrombin inhibitors and as anticoagulants
09/06/1995EP0669940A1 Specifically crosslinked hemoglobin with free functionality
09/06/1995EP0669936A1 Novel mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ace
09/06/1995EP0669912A1 N-(3-piperidinylcarbonyl)-beta-alanine derivatives as paf antagonists
09/06/1995EP0669834A1 Use of topically applied factor xiii for inhibiting hemorrhage
09/06/1995CN1107857A Cyclic amino acid derivativges
09/06/1995CN1107839A Carbox amide
09/06/1995CN1107704A Methods of inhibiting thrombin
09/05/1995US5447959 Vitamin A derivatives
09/05/1995US5447728 A carrier comprising an acylated amino acid; lowering iron concentration in mammals
09/05/1995CA2143542A1 Antithrombotic agents
09/05/1995CA2143541A1 Antithrombotic agents
09/05/1995CA2143536A1 Antithrombotic agents
09/05/1995CA2143534A1 Antithrombotic agents
09/05/1995CA2143533A1 Antithrombotic agents
09/05/1995CA2143532A1 Bisulfite adducts of arginine aldehydes
09/02/1995CA2143603A1 Fatty acid derivatives
08/1995
08/31/1995WO1995023161A1 Growth arrest homeobox gene
08/31/1995WO1995023139A1 Optically pure 4-aryl-2-hydroxytetronic acids
08/31/1995WO1995022986A1 Fibrin-specific antibody for use as an antithrombotic agent
08/31/1995CA2184068A1 Optically pure 4-aryl-2-hydroxytetronic acids
08/31/1995CA2183953A1 Fibrin-specific antibody for use as an antithrombotic agent
08/31/1995CA2183863A1 Growth arrest homeobox gene
08/30/1995EP0669394A1 Bifunctional derivatives of Urokinase with improved fibrinolytic activity and Thrombin inhibiting activity
08/30/1995EP0669342A2 Process to isolate and purify vitamin-K dependent proteins
08/30/1995EP0669131A1 Aquous concentrated solutions containing argatroban
08/30/1995EP0668909A1 Transgenic, cross-linked hemoglobin
08/30/1995EP0668877A1 Displacement chromatography process and purified hemoglobin product
08/30/1995EP0668869A1 2- 3-(4-amidinophenyl)]propionic acid derivatives, their preparation and their use
08/30/1995EP0428541B1 Collagen wound healing matrices and process for their production
08/30/1995CN1107467A 1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present
08/30/1995CN1107365A A novel physiologically active substance
08/30/1995CN1107355A Pharmaceutical preparations having antithrombotic activity and process for preparing same
08/30/1995CN1107341A Compound garlic oil capsule and its producing method
08/29/1995US5446131 Polypeptides or cylic polypeptide; therapeutic and prophylactic; inhibit thrombin-induced platelet aggregation
08/29/1995US5446030 With an anionic oligosaccharide
08/24/1995WO1995022347A1 Pharmaceutical preparation containing plasminogen activators
08/24/1995WO1995022329A1 Agent for prophylaxis and treatment of thromboxane a2-mediated diseases
08/24/1995WO1995022316A1 Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use
08/24/1995DE4405426A1 Pharmazeutisches Präparat enthaltend Plasminogenaktivator (t-PA) oder dessen Derivate A pharmaceutical preparation containing plasminogen activator (t-PA) or derivatives thereof
08/23/1995EP0668357A1 Vector for integration site independent gene expression in mammalian host cells
08/23/1995EP0668354A1 Cysteine added variants of G-CSF and chemical modifications thereof
08/23/1995EP0668353A1 Cysteine added variants of EPO and chemical modifications thereof
08/23/1995EP0668351A1 Erythropoietin isoforms
08/23/1995EP0668279A2 6-Azaindole thromboxane synthase inhibitors
08/23/1995EP0668278A1 Adhesion receptor antagonists
08/23/1995EP0667904A1 Suppressor and progenitor cells
08/23/1995EP0667780A1 Purified ceramide-activated protein kinase, assay for identifying agents which act on same, and methods of using said agents
08/23/1995EP0667777A1 Xanthine derivatives for use as diuretics
08/23/1995EP0667773A1 Fibrinogen receptor antagonists
08/23/1995EP0667770A1 Inhibition of tnf production.
08/23/1995EP0494929B1 Mutants of the human plasminogen activator inhibitor 1 (pai-1), their preparation and use
08/23/1995CN1107159A Linear adhesion inhibitors
08/23/1995CN1107146A A process for preparing a composition containing benzoheterocycles
08/22/1995US5444153 Plasminogen activator inhibitor which has been altered to eliminate a protease sensitive site
08/22/1995US5444049 Peptide compounds derived from boronic acid
08/22/1995US5443972 Fermentation of Streptomyces
08/22/1995US5443827 Chimeric molecule; anticoagulants
08/22/1995CA1336777C Dextro-rotatory enantiomer of methyl alpha-5 (4,5,6,7-tetrahydro (3,2-c) thieno pyridyl) (2-chlorophenyl)-acetate, a process for its preparation and the pharmaceutical compositions containing it
08/20/1995CA2142741A1 Adhesion receptor antagonists
08/17/1995WO1995021920A1 Hematopoietic protein and materials and methods for making it
08/17/1995WO1995021857A1 Novel 2-substituted indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
08/17/1995WO1995021854A1 Novel mercaptoacetylamido 1,3,4,5-tetrahydro-benzo[c]azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace
08/17/1995WO1995021832A1 Pharmaceutical piperazine compounds
08/17/1995WO1995021829A1 Pharmaceutical piperazine compounds
08/17/1995CA2183266A1 Hematopoietic protein and materials and methods for making it
08/17/1995CA2182877A1 Pharmaceutical piperazine compounds
08/17/1995CA2182876A1 Pharmaceutical piperazine compounds
08/17/1995CA2160591A1 Protein having tpo activity
08/16/1995EP0667355A1 Hirudin derivatives and process for their preparation
08/16/1995EP0667345A1 1-Benzyl-3-(substituted aryl)-condensed pyrazole derivatives as inhibitors of platelet aggregation
08/16/1995EP0667158A1 Platelet aggregation inhibitor
08/16/1995EP0666920A1 Thrombin activatable plasminogen derivatives
08/16/1995EP0666736A1 Stabilization of fluorocarbon emulsions.
08/16/1995EP0371999B1 Nucleic acid and methods for the synthesis of novel fusion polypeptides with a phospholipid anchor domain
08/16/1995CN1106819A Tripeptide antithrombotic agents
08/16/1995CN1106806A Adhesion receptor antagonists
08/16/1995CN1106657A Pharmaceutical composition for maintaining and/or reestablishing a near normal blood platelet aggregarion rate
08/15/1995US5442064 Anticoagulants, antiagglomerants
08/15/1995US5441965 Methods of inhibiting thrombin
08/15/1995US5441960 1-pyrimidinylacetamide human leukocyte elastate inhibitors
08/15/1995US5441952 Fibrinogen receptor antagonists
08/15/1995US5441868 Production of recombinant erythropoietin
08/15/1995CA1336679C Remedy for hematopoietic tissue diseases comprising human monocytic macrophage colony stimulating factor as active ingredient
08/11/1995CA2142173A1 Hirudin derivatives and a process for their preparation
08/10/1995WO1995021254A1 Multivariant il-3 hematopoiesis fusion protein
08/10/1995WO1995021197A1 Il-3 variant hematopoiesis fusion protein
08/10/1995WO1995020976A1 Co-administration of interleukin-3 mutants with colony stimulating factors
08/10/1995WO1995020961A1 Vitamin e and derivatives prevent damage in red cells sterilized by phthalocyanines and light
08/10/1995WO1995018830A3 Inhibitors of human plasmin derived from the kunitz domains
08/10/1995WO1995015373A3 Inhibition of dna methyltransferase
08/10/1995CA2182484A1 Multivariant il-3 hematopoiesis fusion protein
1 ... 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 ... 671